Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Veracyte, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
VCYT
Nasdaq
2836
www.veracyte.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Veracyte, Inc.
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
- May 30th, 2026 6:00 am
Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte’s Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy
- May 29th, 2026 1:15 pm
Is it Worth Retaining Veracyte Stock in Your Portfolio for Now?
- May 27th, 2026 9:07 am
Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?
- May 25th, 2026 9:19 am
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago
- May 25th, 2026 6:30 am
Assessing Veracyte (VCYT) Valuation After Phase III Success For Prosigna And Decipher Cancer Tests
- May 23rd, 2026 11:11 am
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
- May 22nd, 2026 6:00 am
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
- May 21st, 2026 4:00 pm
Veracyte to Participate in Upcoming Investor Conferences
- May 19th, 2026 2:05 pm
Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer
- May 15th, 2026 7:00 am
Statutory Profit Doesn't Reflect How Good Veracyte's (NASDAQ:VCYT) Earnings Are
- May 14th, 2026 5:52 am
Why Veracyte Stock Is Skyrocketing Higher This Week
- May 7th, 2026 11:11 pm
Veracyte, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
- May 7th, 2026 1:19 pm
Veracyte (VCYT) Crossed Above the 200-Day Moving Average: What That Means for Investors
- May 7th, 2026 7:30 am
Veracyte Q1 Earnings Call Highlights
- May 5th, 2026 10:08 pm
Veracyte (VCYT) Beats Q1 Earnings and Revenue Estimates
- May 5th, 2026 6:30 pm
Veracyte, Inc. Q1 2026 Earnings Call Summary
- May 5th, 2026 6:18 pm
Veracyte (VCYT) Q1 2026 Earnings Transcript
- May 5th, 2026 4:09 pm
Veracyte Announces First Quarter 2026 Financial Results
- May 5th, 2026 2:05 pm
Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.16%: Read This Before Placing a Bet
- May 5th, 2026 7:55 am
Scroll